AUS
NZ
UK
CA
USA
IND
Healt
COVID-19: What Drove ASX 300 listed Starpharma Share Price Today?
September 01, 2020 05:28 PM AEST| By Team Kalkine MediaSummary ASX 300 healthcare company Starpharma Holdings has applied its novel DEP® drug delivery technology to develop a long-acting, water-soluble formulation of remdesivir. Starpharma’s DEP® remdesivir is a water-soluble nanopart.....
Scan Through SUDA’s Key Operational Achievements in FY 2019-2020
August 31, 2020 08:29 PM AEST| By Team Kalkine MediaSummary SUDA reported key operational achievements for FY 2019-2020. The Company finalised a key agreement with Cann Pharma Australia during the year. The financial year also saw the signing of three significant agreements with Sanofi, Ordesa .....
Australian Cannabis Sector’s Growth Continues; Lens on Althea and MGC Pharmaceuticals
August 30, 2020 12:10 AM AEST| By Team Kalkine MediaThe Australian cannabis industry is growing continuously dodging the impact of COVID-19 pandemic. The cannabis industry in Australia will be able to export in the lucrative US market, Southeast Asia, China, and Canada markets, as the Australian gov.....
ASX 200 Pharma Player Set to Race into the Mighty US Market, With a COVID Kicker; Stock up 4.5x from March Lows
August 28, 2020 11:10 PM AEST| By Team Kalkine MediaA recent ASX200 entrant midcap pharma company, aggressively cutting costs as it prepares to take its drug RYONCIL™ into the mighty US healthcare market. Additionally, this drug is being evaluated in clinical trials against acute respiratory dis...
Why is ASX 200 listed AVITA Therapeutics share price up today despite reporting FY20 loss?
August 28, 2020 05:37 PM AEST| By Team Kalkine MediaSummary ASX 200 listed healthcare company AVITA Therapeutics reported FY20 revenue of US$14.263 million from RECELL Systems, up 161%. However, The Company reported a loss of US$42 million for the year ended 30 June 2020, due to an increase in o.....
5 Healthcare Share Prices Under Discussion Today - Starpharma, Ramsay, Mesoblast, Ansell, CLINUVEL
August 27, 2020 06:57 PM AEST| By Team Kalkine MediaThe current reporting season has been challenging for many sectors with the double whammy of bushfires and COVID-19 pandemic weighing down businesses. However, the ongoing market turmoil has created an opportunity for the healthcare sector. S.....
PTX Solidifies Balance Sheet Further: Announces A$7 million Placement to Support Expanded Pipeline of Innovative Cancer Therapies
August 26, 2020 07:51 PM AEST| By Team Kalkine MediaOn 26 August 2020, Prescient Therapeutics Limited (ASX:PTX) announced that it has received firm commitments to raise A$7,046,084 (before costs) by way of a share placement of 128,110,611 fully paid ordinary shares to professional as well as sophist.....
What’s defining the momentum for these ASX 300 listed healthcare share prices: IDX, NAN, ANN
August 26, 2020 12:00 AM AEST| By Team Kalkine MediaDuring the current reporting season, healthcare companies have reported impressive financial results amid the opportunities created by COVID-19 pandemic in the healthcare sector. The share price of ASX listed healthcare companies remains on watch a.....
The All Ordinaries Healthcare Share Price Under Discussion - SomnoMed
August 25, 2020 02:24 PM AEST| By Team Kalkine MediaSummary With a high prevalence that is expected to grow further, the obstructive sleep apnea (OSA) market is predicted to expand in the upcoming times. Sydney-headquartered SomnoMed Limited, engaged in developing devices for OSA treatment, repo.....
Imugene Receives Third Ethics Approval for PD1-Vaxx’s Phase 1 Trial in Australia
August 24, 2020 12:32 PM AEST| By Team Kalkine MediaThe stock of Australian clinical-stage immuno-oncology company, Imugene Limited (ASX:IMU) traded ~1.8 per cent higher on 21st August 2020 following the release of a significant update on PD1-Vaxx’s third ethics approval for Phase 1 trial. To.....
Needle on CardieX Limited: What's Driving the Impressive Stock Performance?
August 23, 2020 12:15 AM AEST| By Hina ChowdharyGlobal health technology company, CardieX Limited (ASX:CDX) has experienced a stupendous price rally with a six-month investor return of more than 107% and three-month investor return of 145.45%, as on 20 August 2020. The increase can be attributed.....
E-health Services - the Apparent Next Step Amid Digital Boom and Pandemic
August 22, 2020 01:28 AM AEST| By Team Kalkine MediaSummary Australian government intends to develop a national approach for digital health; however, challenges are hampering the pace of development. MedAdvisor reported a record revenue during Q4, up 41 per cent year-on-year, while FY20 reve.....
2 Healthcare Stocks to Watch Today: Healius, Mayne Pharma
August 21, 2020 08:55 PM AEST| By Team Kalkine MediaSummary Healius reported FY20 results which were in line with the guidance provided. Underlying EBIT and underlying NPAT were A$102.7 million and A$55.4 million, respectively. Resilience in Healius’ Pathology division continued into July .....
One Mid-cap All Ordinaries Healthcare Player that Investors Like: EBOS Share Price
August 21, 2020 05:08 PM AEST| By Team Kalkine MediaSummary Marketer and distributor of healthcare products, EBOS Group, witnessed strong performances from both Healthcare and Animal Care segments in FY20; total revenue grew by 26.5%. With the distribution of healthcare products falling under es.....
Is this ASX 200 Healthcare Player Still a Buy Post a Bullish Run? Sonic Healthcare
August 20, 2020 06:15 PM AEST| By Team Kalkine MediaThe share price of healthcare companies is on a watch as they announce impressive full-year results during the current reporting season. Many ASX 200 healthcare players have updated impressive FY20 results despite the challenging condition posed by.....
Next move on Vaccine: Government's agreement with AstraZeneca catering 25 million Australians
August 20, 2020 04:47 PM AEST| By Team Kalkine MediaRecently, Australia undertook strides to secure access to a promising vaccine in a move to diminish coronavirus pandemic and would offer free access to the vaccine for Australians. Scott Morrison Government has signed a landmark agreement with UK-.....
Popular Healthcare ASX Share Prices: CSL, Medical Developments
August 19, 2020 06:16 PM AEST| By Team Kalkine MediaSummary CSL Limited reported an NPAT of ~US$2,103 million for FY20, up 17% on a constant currency basis. The total full-year dividend rose to US$2.02 per share. CSL’s FY21 NPAT is expected to be in the range US$2,100-US$2,265 million at c.....
Is CSL share price still a buy this year?
August 19, 2020 04:01 PM AEST| By Team Kalkine MediaSummary Biotech player CSL Limited announced its FY20 results with an impressive growth of 17% and 9% in net profit after tax and revenue, respectively (on constant currency basis). CSL had earlier announced the initiation of first human trials.....
Healthcare Dynasty with Fisher & Paykel Share Price & Cochlear Post Profit/Loss Reporting
August 19, 2020 12:15 AM AEST| By Kunal SawhneySummary Hospital hardware sales of Fisher & Paykel have continued to steadily increase over the first four months of FY21 with over 390% cc revenue growth to the end of July compared to pcp. Fisher & Paykel disclosed that, at current ex.....
Latest updates in healthcare space: Lens on EMD and AT1
August 16, 2020 12:34 AM AEST| By Kunal SawhneySince the onset of a pandemic, the health system of Australia has experienced both challenges and opportunities as a result of COVID-19. Many companies are involved in preparing a vaccine for the global pandemic, and some are in various stages of c.....
Advertise your brand on Kalkine Media